Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin vs Levofloxacin for UTI Prevention Post-Urodynamics
NCT06017479Phase 2Completed
- Sponsor
- Universitas Indonesia
- Start
- Dec 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosfomycin, levofloxacin in urinary tract infection (UTI), sponsored by Universitas Indonesia. Started Dec 2022; status: completed.
02
Drugs
fosfomycinlevofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06017479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06017479.